Challenges in Disease Elimination 12-16 September 2016
 

RSTMH are very excited about our Challenges in Disease Elimination meeting. You may be aware that this is now a five-day meeting, incorporating the Challenges in Malaria Research meeting previously run by BioMed Central. We have chosen the over-arching theme of disease elimination for this year’s meeting; informed by the outcomes of our policy-focussed meeting in September 2015, we will cover a range of diseases including leprosy, yaws, trachoma, polio, neo-natal mortality and still-birth, with a focus solely on malaria on days 4 and 5.

A fantastic line up of speakers
We have been fortunate to attract a distinguished array of keynote speakers, session chairs and co-chairs. We would like to specifically mention Nicolas Grassly Head of Vaccine Epidemiology Research based at Imperial and our very own RSTMH Vice President Sarah Rowland-Jones.
Why not take some time to get to know our Speakers via our website?

Abstract submission and registration are now open
The call for abstracts is now open and will close on 01 June midday UK time. As with all of our meetings, registration has been discounted for RSTMH members, so why not join RSTMH and receive a discount on your registration today?

Sponsorship
Do you know of somebody who might like to exhibit at this meeting? We have a range of sponsorship opportunities available to accommodate all organisations and budgets. More information can be found on the Challenges in Disease Elimination website.

Spotlight on April Transactions

The April issue of Transactions is now available online and includes three Open Access and freely available papers: an Editorial by ASTMH President Dr Steven Higgs and Dr Dana L Vanlandingham entitled Search and one will find: Zika virus everywhere, an Open Access Commentary by Dr Matthew Baylis and colleagues entitled Emergence or improved detection of Japanese encephalitis virus in the Himalayan highlands? and lastly an Editor's Choice Review Paper by Dr Helen Fletcher and Dr Lewis Schrager on TB vaccine development and the End TB Strategy: importance and current status

The issue is freely available to view until 30 April and in perpetuity by anyone with a subscription to RSTMH. If you haven't already subscribed to our journals, why not become a member today? You’ll gain access to the full 108-year archive of scholarly articles alongside many more benefits.